Tenascin-C-Matrix Metalloproteinase-3 Phenotype and the Risk of Tendinopathy in High-Performance Athletes: A...

Area of Science:

• Genetics and Sports Medicine
• Extracellular Matrix Biology
• Tendinopathy Pathogenesis

Background:

• Tendon structure relies heavily on the extracellular matrix (ECM).
• Genetic variations in ECM components may predispose individuals to tendinopathy.
• Investigating specific gene polymorphisms in athletes is crucial for understanding susceptibility.

Purpose of the Study:

• To examine the association between single nucleotide polymorphisms (SNPs) in FBN2, TNC, and MMP3 genes and tendinopathy.
• To evaluate the influence of these SNPs on the tendon regeneration failure phenotype in Brazilian high-performance athletes.
• To determine the impact of genetic variants on susceptibility to tendinopathy and disease recurrence.

Main Methods:

• A case-control study involving 397 high-performance athletes (197 tendinopathy cases, 200 controls).
• Genotyping of specific SNPs: FBN2 (rs331079), TNC (rs2104772), and MMP3 (rs591058) using TaqMan assays.
• Statistical analysis to assess the association between genotypes, tendinopathy, and disease manifestation episodes.

Main Results:

• The TNC-rs2104772-A allele was significantly associated with tendinopathy (OR: 1.4).
• The MMP3-rs591058-T allele increased the risk of multiple disease episodes (OR: 1.7).
• The combined TNC-A/MMP3-T genotype correlated with higher risks of tendinopathy (OR: 1.4) and recurrent episodes (OR: 2.0), particularly >3 exacerbations (OR: 4.3).

Conclusions:

• Specific SNPs in TNC (rs2104772) and MMP3 (rs591058) may contribute to the tendon regeneration failure phenotype.
• These genetic variants might influence molecular mechanisms regulating tendon ECM under training stress.
• Findings suggest a genetic predisposition to tendinopathy and its recurrence in athletes.